We recognize that the ongoing intermittent shortages of Ozempic has created unexpected challenges for those managing Type 2 diabetes. Unfortunately, this has been extended to March 2024 and is now impacting other dosages.
Medavie Blue Cross is committed to providing support and guidance during this challenging period. Please take a moment to read through the information below, which outlines proactive measures and alternative options to ensure your uninterrupted diabetes management.
What proactive measures can I take?
If you live with diabetes and the shortages of Ozempic are affecting you, we encourage you to:
What alternative medications can I claim and are they approved under my plan?
Our aim is to support you with evidence-based diabetes treatments which may include one of the following options:
If I submit a first-time claim without having used Ozempic before, will it be approved?
Until supplies are restored, any new initial treatment claims received for Ozempic will require you try another eligible Type 2 diabetes drug first. If not, your claim will be denied.
If I’m switching coverage from another benefits provider and I’ve been treating my Type 2 diabetes with Ozempic, will my claim be approved?
If you are currently on Ozempic, previously covered by another plan, we will approve your claim as we do not consider these new prescriptions.
My prescriber recommends an interim weight loss drug with a similar composition to Ozempic– can I claim that instead?
Only medications authorized for the treatment of Type 2 diabetes will be approved. This does not include weight management drugs or any off-label medications. If you have specific concerns or considerations regarding weight management, we encourage you to discuss them with your healthcare professional to explore suitable alternatives.
The alternative drugs specified above are only for the interim until Ozempic supplies can be restored.
How can I know which drugs I’m eligible for?